Paul Rebattu
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Molecular Biology
- Genetics top 10%
- Pathology and Forensic Medicine
- Co-authors
- C ArdietBrigitte TranchandJean-Luc BretonThierry PhilipPierre BironR RiouM. PérolLuc Thiberville
- Topics
- Lung Cancer Treatments and Mutations (13 papers)Cancer Treatment and Pharmacology (13 papers)Lung Cancer Research Studies (11 papers)
- Partner nations
- FranceUnited StatesBelgium
In The Last Decade
Paul Rebattu
53 papers receiving 900 citations
Peers
Comparison fields: 5 of 93
- Oncology 580
- Pulmonary and Respiratory Medicine 440
- Molecular Biology 150
- Genetics 135
- Pathology and Forensic Medicine 114
Countries citing papers authored by Paul Rebattu
This map shows the geographic impact of Paul Rebattu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Rebattu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Rebattu more than expected).
Fields of papers citing papers by Paul Rebattu
This network shows the impact of papers produced by Paul Rebattu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Rebattu. The network helps show where Paul Rebattu may publish in the future.
Co-authorship network of co-authors of Paul Rebattu
This figure shows the co-authorship network connecting the top 25 collaborators of Paul Rebattu. A scholar is included among the top collaborators of Paul Rebattu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Rebattu. Paul Rebattu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 8 | |
| 3 | 12 | |
| 4 | 33 | |
| 5 | 5 | |
| 6 | Étude prospective de qualité des soins et de qualité de vie chez des patients cancéreux en phase palliative, en hospitalisation ou à domicile : analyse intermédiaire de l’étude Trapado | 7 |
| 7 | 101 | |
| 8 | 2 | |
| 9 | 35 | |
| 10 | 24 | |
| 11 | 23 | |
| 12 | 1 | |
| 13 | 9 | |
| 14 | 4 | |
| 15 | 0 | |
| 16 | 8 | |
| 17 | 12 | |
| 18 | 22 | |
| 19 | 6 | |
| 20 | [Monoclonal gammopathy, apparently non-myelomatous, associated with non-A non-B hepatitis antigen]. | 1 |
About Paul Rebattu
Paul Rebattu is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Anesthesiology and Pain Medicine, having authored 56 papers that have together received 943 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (13 papers), Cancer Treatment and Pharmacology (13 papers) and Lung Cancer Research Studies (11 papers). The work is most often cited by research in Oncology (580 citations), Pulmonary and Respiratory Medicine (440 citations) and Genetics (135 citations). Paul Rebattu has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include C Ardiet, Brigitte Tranchand, Jean-Luc Breton, Thierry Philip, Pierre Biron, R Riou, M. Pérol, Luc Thiberville, Yacine Merrouche and G. Robinet. Their work appears in journals such as Journal of Clinical Oncology, CHEST Journal and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.